Belfast, United Kingdom
Belfast, United Kingdom

Andor Technology Ltd is a developer and manufacturer of high performance light measuring solutions . It became a subsidiary of Oxford Instruments after it was purchased for £176m in December 2013.Andor Technology was set up by its founders, Dr. Hugh Cormican, Dr. Donal Denvir and Mr. Mike Pringle in the mid-1980s. While studying at Queen's University Belfast, they "used their physics know-how to build a highly sensitive digital camera...as a tool for their laser research." They subsequently set up Andor Technology to develop it into a commercial product for use in scientific research.Andor Technology Ltd was established in 1989, as a spin out from Queen's University, Belfast. In December 2004 the company became a PLC when it listed on the Alternative Investment Market of the London Stock Exchange.The company is based in Belfast, Northern Ireland, and it designs and manufactures and sells scientific imaging equipment including charge-coupled device , electron-multiplying CCD and Intensified charge-coupled device camera systems, spectroscopy instrumentation, and microscopy systems. The cameras can be used for low light imaging, spectroscopy, X-ray, time resolved, and microscopy studies and have a wide range of users including physicists, biologists, life scientists, geneticists and nano-technologists all around the world.Andor introduced its first EMCCD camera, the DV 465 in 2001 and the company was awarded The Photonics Circle of Excellence Awards from Laurin Publishing, which recognizes the 25 Most Technically Innovative New Products of the Year.EMCCD is based on a CCD chip that incorporates electron multiplication, or EMCCD technology. It is used in fields such as drug discovery, where scientists need to watch vats of chemicals in real time, astrophysics, and oceanography.In June 2010, Andor Technology announced a profits rise by 87%. Wikipedia.


Time filter

Source Type

Sarasota, FL, May 08, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Biophotonics Market by Application (See-Through Imaging, Microscopy, Inside Imaging, Spectro Molecular, Light Therapy, Surface Imaging, and Biosensors) for Test & Components, Medical Therapeutics, Medical Diagnostics, and Non-Medical End-use: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global biophotonics market was valued at around USD 29.08 billion in 2015 and is expected to reach approximately at USD 54.39 billion by 2021, growing at a CAGR of around 11.2% between 2016 and 2021. Biophotonics is a promising area of scientific research which deals with interactions between biological matter and light. Biophotonics is the science and technology of generating and harnessing photons to manipulate and detect biological materials. Biophotonics uses light beams and forms of energy to diagnose and monitor medical conditions. Browse through 27 Market Tables and 19 Figures spread through 110 Pages and in-depth TOC on “Global Biophotonics Market: By Application, End-use Segment, Size, Share & Trends to 2015 – 2021”. Global biophotonics market is expected to witness lucrative growth over the forecast period owing to increasing geriatric population coupled with rising frequency of chronic diseases. The other key factors predisposing to the growth of biophotonics market include increasing government initiatives and incorporation of IT into the health care applications across the globe. Moreover, the increase in the number of photonic components in the healthcare instruments for higher accuracy & sensitivity and value improvement is expected to propel the market growth in the years to come.However, the high price of biophotonics-based instruments coupled with the complexity of the biophotonics technology may curb the market growth in the near future. Nevertheless, the significant technological advancements over the decade and their adoption in the medical sector are expected to open up new growth opportunities within the forecast period. Based on application, biophotonics market is classified into see-through imaging, microscopy, inside imaging, spectro molecular, light therapy, surface imaging, and biosensors. In 2015, see-through imaging held the largest share and is expected to witness strong growth in the near future. This is mainly due to strong demand for radical non-invasive surgical procedures in medical sectors, such as brain imaging, cardiology, neurology, Non-medical, and oncology. Browse the full "Biophotonics Market by Application (See-Through Imaging, Microscopy, Inside Imaging, Spectro Molecular, Light Therapy, Surface Imaging, and Biosensors) for Test & Components, Medical Therapeutics, Medical Diagnostics, and Non-Medical End-Use: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021" report at https://www.zionmarketresearch.com/report/biophotonics-market The biophotonics market is segmented on the basis of end-use into test & components, medical therapeutics, medical diagnostics, and non-medical. In 2015, medical diagnostics dominated the biophotonics market is expected to experienced substantial growth in the years to come. This growth is mainly attributed to adoption by different end-users which include healthcare providers, research laboratories, and instrument menu. The non-medical segment is expected to witness the fastest growth in the coming years it's environmental screening and monitoring capabilities. In terms of revenue, North America held the largest share of the global biophotonics market and is set to dominate the world marketplace within the forecast period. This growth is mainly attributed to the increasing demand for treatment from the aging population. Moreover, high investments in the healthcare industry, surging R&D initiatives and accessibility to the excellent infrastructure is further expected to propel the market growth in the near future in this region. The U.S. was the largest biophotonics market in 2015. Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/biophotonics-market Asia Pacific biophotonics market is projected to be a fastest growing regional market in the near future. Furthermore, biophotonics market has a huge opportunity in the emerging markets of Asia Pacific due to the increasing aging population, rising health awareness about biophotonics treatment and increasing investment in the healthcare sector especially in China and India. Europe is expected to exhibit witness significant growth in the years to come. The growth is mainly due to increased concern regarding health among people. Moreover, technological advancement and improvement in health care infrastructure are expected to fuel the market growth within the forecast period. Middle East & Africa is expected to witness significant growth in the near future. This growth is mainly due to the increasing healthcare awareness coupled with advancement in technology. Latin America is another important regional market and is expected to experience significant growth over the forecast period. The growth is mainly due to the increasing demand for biophotonics treatment coupled with technological advancement. The Latin America biophotonics market led by Brazil on account of increasing health awareness couple with rising number of sports injuries. Thus, all aforementioned parameters are expected to drive the market growth in this region. The key market players comprise Carl Zeiss, LumenisLtd., Hamamatsu Photonics K.K., Becton, Dickinson and Company, Olympus Corporation, Perkinelmer, Inc., Andor Technology Ltd, Affymetrix Inc., FEI Company and Olympus America. This report segments the global biophotonics market as follows: Global Biophotonics Market: End-use Segment Analysis Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.


Sarasota, FL, May 08, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Biophotonics Market by Application (See-Through Imaging, Microscopy, Inside Imaging, Spectro Molecular, Light Therapy, Surface Imaging, and Biosensors) for Test & Components, Medical Therapeutics, Medical Diagnostics, and Non-Medical End-use: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global biophotonics market was valued at around USD 29.08 billion in 2015 and is expected to reach approximately at USD 54.39 billion by 2021, growing at a CAGR of around 11.2% between 2016 and 2021. Biophotonics is a promising area of scientific research which deals with interactions between biological matter and light. Biophotonics is the science and technology of generating and harnessing photons to manipulate and detect biological materials. Biophotonics uses light beams and forms of energy to diagnose and monitor medical conditions. Browse through 27 Market Tables and 19 Figures spread through 110 Pages and in-depth TOC on “Global Biophotonics Market: By Application, End-use Segment, Size, Share & Trends to 2015 – 2021”. Global biophotonics market is expected to witness lucrative growth over the forecast period owing to increasing geriatric population coupled with rising frequency of chronic diseases. The other key factors predisposing to the growth of biophotonics market include increasing government initiatives and incorporation of IT into the health care applications across the globe. Moreover, the increase in the number of photonic components in the healthcare instruments for higher accuracy & sensitivity and value improvement is expected to propel the market growth in the years to come.However, the high price of biophotonics-based instruments coupled with the complexity of the biophotonics technology may curb the market growth in the near future. Nevertheless, the significant technological advancements over the decade and their adoption in the medical sector are expected to open up new growth opportunities within the forecast period. Based on application, biophotonics market is classified into see-through imaging, microscopy, inside imaging, spectro molecular, light therapy, surface imaging, and biosensors. In 2015, see-through imaging held the largest share and is expected to witness strong growth in the near future. This is mainly due to strong demand for radical non-invasive surgical procedures in medical sectors, such as brain imaging, cardiology, neurology, Non-medical, and oncology. Browse the full "Biophotonics Market by Application (See-Through Imaging, Microscopy, Inside Imaging, Spectro Molecular, Light Therapy, Surface Imaging, and Biosensors) for Test & Components, Medical Therapeutics, Medical Diagnostics, and Non-Medical End-Use: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021" report at https://www.zionmarketresearch.com/report/biophotonics-market The biophotonics market is segmented on the basis of end-use into test & components, medical therapeutics, medical diagnostics, and non-medical. In 2015, medical diagnostics dominated the biophotonics market is expected to experienced substantial growth in the years to come. This growth is mainly attributed to adoption by different end-users which include healthcare providers, research laboratories, and instrument menu. The non-medical segment is expected to witness the fastest growth in the coming years it's environmental screening and monitoring capabilities. In terms of revenue, North America held the largest share of the global biophotonics market and is set to dominate the world marketplace within the forecast period. This growth is mainly attributed to the increasing demand for treatment from the aging population. Moreover, high investments in the healthcare industry, surging R&D initiatives and accessibility to the excellent infrastructure is further expected to propel the market growth in the near future in this region. The U.S. was the largest biophotonics market in 2015. Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/biophotonics-market Asia Pacific biophotonics market is projected to be a fastest growing regional market in the near future. Furthermore, biophotonics market has a huge opportunity in the emerging markets of Asia Pacific due to the increasing aging population, rising health awareness about biophotonics treatment and increasing investment in the healthcare sector especially in China and India. Europe is expected to exhibit witness significant growth in the years to come. The growth is mainly due to increased concern regarding health among people. Moreover, technological advancement and improvement in health care infrastructure are expected to fuel the market growth within the forecast period. Middle East & Africa is expected to witness significant growth in the near future. This growth is mainly due to the increasing healthcare awareness coupled with advancement in technology. Latin America is another important regional market and is expected to experience significant growth over the forecast period. The growth is mainly due to the increasing demand for biophotonics treatment coupled with technological advancement. The Latin America biophotonics market led by Brazil on account of increasing health awareness couple with rising number of sports injuries. Thus, all aforementioned parameters are expected to drive the market growth in this region. The key market players comprise Carl Zeiss, LumenisLtd., Hamamatsu Photonics K.K., Becton, Dickinson and Company, Olympus Corporation, Perkinelmer, Inc., Andor Technology Ltd, Affymetrix Inc., FEI Company and Olympus America. This report segments the global biophotonics market as follows: Global Biophotonics Market: End-use Segment Analysis Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.


Sarasota, FL, May 08, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Biophotonics Market by Application (See-Through Imaging, Microscopy, Inside Imaging, Spectro Molecular, Light Therapy, Surface Imaging, and Biosensors) for Test & Components, Medical Therapeutics, Medical Diagnostics, and Non-Medical End-use: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global biophotonics market was valued at around USD 29.08 billion in 2015 and is expected to reach approximately at USD 54.39 billion by 2021, growing at a CAGR of around 11.2% between 2016 and 2021. Biophotonics is a promising area of scientific research which deals with interactions between biological matter and light. Biophotonics is the science and technology of generating and harnessing photons to manipulate and detect biological materials. Biophotonics uses light beams and forms of energy to diagnose and monitor medical conditions. Browse through 27 Market Tables and 19 Figures spread through 110 Pages and in-depth TOC on “Global Biophotonics Market: By Application, End-use Segment, Size, Share & Trends to 2015 – 2021”. Global biophotonics market is expected to witness lucrative growth over the forecast period owing to increasing geriatric population coupled with rising frequency of chronic diseases. The other key factors predisposing to the growth of biophotonics market include increasing government initiatives and incorporation of IT into the health care applications across the globe. Moreover, the increase in the number of photonic components in the healthcare instruments for higher accuracy & sensitivity and value improvement is expected to propel the market growth in the years to come.However, the high price of biophotonics-based instruments coupled with the complexity of the biophotonics technology may curb the market growth in the near future. Nevertheless, the significant technological advancements over the decade and their adoption in the medical sector are expected to open up new growth opportunities within the forecast period. Based on application, biophotonics market is classified into see-through imaging, microscopy, inside imaging, spectro molecular, light therapy, surface imaging, and biosensors. In 2015, see-through imaging held the largest share and is expected to witness strong growth in the near future. This is mainly due to strong demand for radical non-invasive surgical procedures in medical sectors, such as brain imaging, cardiology, neurology, Non-medical, and oncology. Browse the full "Biophotonics Market by Application (See-Through Imaging, Microscopy, Inside Imaging, Spectro Molecular, Light Therapy, Surface Imaging, and Biosensors) for Test & Components, Medical Therapeutics, Medical Diagnostics, and Non-Medical End-Use: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021" report at https://www.zionmarketresearch.com/report/biophotonics-market The biophotonics market is segmented on the basis of end-use into test & components, medical therapeutics, medical diagnostics, and non-medical. In 2015, medical diagnostics dominated the biophotonics market is expected to experienced substantial growth in the years to come. This growth is mainly attributed to adoption by different end-users which include healthcare providers, research laboratories, and instrument menu. The non-medical segment is expected to witness the fastest growth in the coming years it's environmental screening and monitoring capabilities. In terms of revenue, North America held the largest share of the global biophotonics market and is set to dominate the world marketplace within the forecast period. This growth is mainly attributed to the increasing demand for treatment from the aging population. Moreover, high investments in the healthcare industry, surging R&D initiatives and accessibility to the excellent infrastructure is further expected to propel the market growth in the near future in this region. The U.S. was the largest biophotonics market in 2015. Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/biophotonics-market Asia Pacific biophotonics market is projected to be a fastest growing regional market in the near future. Furthermore, biophotonics market has a huge opportunity in the emerging markets of Asia Pacific due to the increasing aging population, rising health awareness about biophotonics treatment and increasing investment in the healthcare sector especially in China and India. Europe is expected to exhibit witness significant growth in the years to come. The growth is mainly due to increased concern regarding health among people. Moreover, technological advancement and improvement in health care infrastructure are expected to fuel the market growth within the forecast period. Middle East & Africa is expected to witness significant growth in the near future. This growth is mainly due to the increasing healthcare awareness coupled with advancement in technology. Latin America is another important regional market and is expected to experience significant growth over the forecast period. The growth is mainly due to the increasing demand for biophotonics treatment coupled with technological advancement. The Latin America biophotonics market led by Brazil on account of increasing health awareness couple with rising number of sports injuries. Thus, all aforementioned parameters are expected to drive the market growth in this region. The key market players comprise Carl Zeiss, LumenisLtd., Hamamatsu Photonics K.K., Becton, Dickinson and Company, Olympus Corporation, Perkinelmer, Inc., Andor Technology Ltd, Affymetrix Inc., FEI Company and Olympus America. This report segments the global biophotonics market as follows: Global Biophotonics Market: End-use Segment Analysis Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.


Sarasota, FL, May 08, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Biophotonics Market by Application (See-Through Imaging, Microscopy, Inside Imaging, Spectro Molecular, Light Therapy, Surface Imaging, and Biosensors) for Test & Components, Medical Therapeutics, Medical Diagnostics, and Non-Medical End-use: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global biophotonics market was valued at around USD 29.08 billion in 2015 and is expected to reach approximately at USD 54.39 billion by 2021, growing at a CAGR of around 11.2% between 2016 and 2021. Biophotonics is a promising area of scientific research which deals with interactions between biological matter and light. Biophotonics is the science and technology of generating and harnessing photons to manipulate and detect biological materials. Biophotonics uses light beams and forms of energy to diagnose and monitor medical conditions. Browse through 27 Market Tables and 19 Figures spread through 110 Pages and in-depth TOC on “Global Biophotonics Market: By Application, End-use Segment, Size, Share & Trends to 2015 – 2021”. Global biophotonics market is expected to witness lucrative growth over the forecast period owing to increasing geriatric population coupled with rising frequency of chronic diseases. The other key factors predisposing to the growth of biophotonics market include increasing government initiatives and incorporation of IT into the health care applications across the globe. Moreover, the increase in the number of photonic components in the healthcare instruments for higher accuracy & sensitivity and value improvement is expected to propel the market growth in the years to come.However, the high price of biophotonics-based instruments coupled with the complexity of the biophotonics technology may curb the market growth in the near future. Nevertheless, the significant technological advancements over the decade and their adoption in the medical sector are expected to open up new growth opportunities within the forecast period. Based on application, biophotonics market is classified into see-through imaging, microscopy, inside imaging, spectro molecular, light therapy, surface imaging, and biosensors. In 2015, see-through imaging held the largest share and is expected to witness strong growth in the near future. This is mainly due to strong demand for radical non-invasive surgical procedures in medical sectors, such as brain imaging, cardiology, neurology, Non-medical, and oncology. Browse the full "Biophotonics Market by Application (See-Through Imaging, Microscopy, Inside Imaging, Spectro Molecular, Light Therapy, Surface Imaging, and Biosensors) for Test & Components, Medical Therapeutics, Medical Diagnostics, and Non-Medical End-Use: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021" report at https://www.zionmarketresearch.com/report/biophotonics-market The biophotonics market is segmented on the basis of end-use into test & components, medical therapeutics, medical diagnostics, and non-medical. In 2015, medical diagnostics dominated the biophotonics market is expected to experienced substantial growth in the years to come. This growth is mainly attributed to adoption by different end-users which include healthcare providers, research laboratories, and instrument menu. The non-medical segment is expected to witness the fastest growth in the coming years it's environmental screening and monitoring capabilities. In terms of revenue, North America held the largest share of the global biophotonics market and is set to dominate the world marketplace within the forecast period. This growth is mainly attributed to the increasing demand for treatment from the aging population. Moreover, high investments in the healthcare industry, surging R&D initiatives and accessibility to the excellent infrastructure is further expected to propel the market growth in the near future in this region. The U.S. was the largest biophotonics market in 2015. Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/biophotonics-market Asia Pacific biophotonics market is projected to be a fastest growing regional market in the near future. Furthermore, biophotonics market has a huge opportunity in the emerging markets of Asia Pacific due to the increasing aging population, rising health awareness about biophotonics treatment and increasing investment in the healthcare sector especially in China and India. Europe is expected to exhibit witness significant growth in the years to come. The growth is mainly due to increased concern regarding health among people. Moreover, technological advancement and improvement in health care infrastructure are expected to fuel the market growth within the forecast period. Middle East & Africa is expected to witness significant growth in the near future. This growth is mainly due to the increasing healthcare awareness coupled with advancement in technology. Latin America is another important regional market and is expected to experience significant growth over the forecast period. The growth is mainly due to the increasing demand for biophotonics treatment coupled with technological advancement. The Latin America biophotonics market led by Brazil on account of increasing health awareness couple with rising number of sports injuries. Thus, all aforementioned parameters are expected to drive the market growth in this region. The key market players comprise Carl Zeiss, LumenisLtd., Hamamatsu Photonics K.K., Becton, Dickinson and Company, Olympus Corporation, Perkinelmer, Inc., Andor Technology Ltd, Affymetrix Inc., FEI Company and Olympus America. This report segments the global biophotonics market as follows: Global Biophotonics Market: End-use Segment Analysis Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.


Sarasota, FL, May 08, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Biophotonics Market by Application (See-Through Imaging, Microscopy, Inside Imaging, Spectro Molecular, Light Therapy, Surface Imaging, and Biosensors) for Test & Components, Medical Therapeutics, Medical Diagnostics, and Non-Medical End-use: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global biophotonics market was valued at around USD 29.08 billion in 2015 and is expected to reach approximately at USD 54.39 billion by 2021, growing at a CAGR of around 11.2% between 2016 and 2021. Biophotonics is a promising area of scientific research which deals with interactions between biological matter and light. Biophotonics is the science and technology of generating and harnessing photons to manipulate and detect biological materials. Biophotonics uses light beams and forms of energy to diagnose and monitor medical conditions. Browse through 27 Market Tables and 19 Figures spread through 110 Pages and in-depth TOC on “Global Biophotonics Market: By Application, End-use Segment, Size, Share & Trends to 2015 – 2021”. Global biophotonics market is expected to witness lucrative growth over the forecast period owing to increasing geriatric population coupled with rising frequency of chronic diseases. The other key factors predisposing to the growth of biophotonics market include increasing government initiatives and incorporation of IT into the health care applications across the globe. Moreover, the increase in the number of photonic components in the healthcare instruments for higher accuracy & sensitivity and value improvement is expected to propel the market growth in the years to come.However, the high price of biophotonics-based instruments coupled with the complexity of the biophotonics technology may curb the market growth in the near future. Nevertheless, the significant technological advancements over the decade and their adoption in the medical sector are expected to open up new growth opportunities within the forecast period. Based on application, biophotonics market is classified into see-through imaging, microscopy, inside imaging, spectro molecular, light therapy, surface imaging, and biosensors. In 2015, see-through imaging held the largest share and is expected to witness strong growth in the near future. This is mainly due to strong demand for radical non-invasive surgical procedures in medical sectors, such as brain imaging, cardiology, neurology, Non-medical, and oncology. Browse the full "Biophotonics Market by Application (See-Through Imaging, Microscopy, Inside Imaging, Spectro Molecular, Light Therapy, Surface Imaging, and Biosensors) for Test & Components, Medical Therapeutics, Medical Diagnostics, and Non-Medical End-Use: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021" report at https://www.zionmarketresearch.com/report/biophotonics-market The biophotonics market is segmented on the basis of end-use into test & components, medical therapeutics, medical diagnostics, and non-medical. In 2015, medical diagnostics dominated the biophotonics market is expected to experienced substantial growth in the years to come. This growth is mainly attributed to adoption by different end-users which include healthcare providers, research laboratories, and instrument menu. The non-medical segment is expected to witness the fastest growth in the coming years it's environmental screening and monitoring capabilities. In terms of revenue, North America held the largest share of the global biophotonics market and is set to dominate the world marketplace within the forecast period. This growth is mainly attributed to the increasing demand for treatment from the aging population. Moreover, high investments in the healthcare industry, surging R&D initiatives and accessibility to the excellent infrastructure is further expected to propel the market growth in the near future in this region. The U.S. was the largest biophotonics market in 2015. Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/biophotonics-market Asia Pacific biophotonics market is projected to be a fastest growing regional market in the near future. Furthermore, biophotonics market has a huge opportunity in the emerging markets of Asia Pacific due to the increasing aging population, rising health awareness about biophotonics treatment and increasing investment in the healthcare sector especially in China and India. Europe is expected to exhibit witness significant growth in the years to come. The growth is mainly due to increased concern regarding health among people. Moreover, technological advancement and improvement in health care infrastructure are expected to fuel the market growth within the forecast period. Middle East & Africa is expected to witness significant growth in the near future. This growth is mainly due to the increasing healthcare awareness coupled with advancement in technology. Latin America is another important regional market and is expected to experience significant growth over the forecast period. The growth is mainly due to the increasing demand for biophotonics treatment coupled with technological advancement. The Latin America biophotonics market led by Brazil on account of increasing health awareness couple with rising number of sports injuries. Thus, all aforementioned parameters are expected to drive the market growth in this region. The key market players comprise Carl Zeiss, LumenisLtd., Hamamatsu Photonics K.K., Becton, Dickinson and Company, Olympus Corporation, Perkinelmer, Inc., Andor Technology Ltd, Affymetrix Inc., FEI Company and Olympus America. This report segments the global biophotonics market as follows: Global Biophotonics Market: End-use Segment Analysis Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.


Grant
Agency: European Commission | Branch: FP7 | Program: CP-FP | Phase: HEALTH-2009-1.2-1 | Award Amount: 2.34M | Year: 2010

Since the histopathological diagnosis of tumours is based on microscopy, it would be highly desirable to possess a microscopical technique allowing morphological investigation with a wide zoom range, high resolution and the implementation of multiplex staining. Thus, the goal of the REMEDI project is to explore the possibilites of novel light microscopy techniques, which overcome the diffraction limit of visible light and extend the range of observation to the molecular level of proteins in tumour cells and analyze their interaction and spatial distribution. This proposal aims at the use of single-molecule-microscopy of cancer tissue samples with ultra-high sensitivity, simplified handling and increased speed of analysis. This shall be accomplished by the development of a novel resolution-enhanced microscopy platform with an integrated novel CMOS camera and an adequate image acquistion and analysis software. The REMEDI platform will be validated with two relevant applications: diagnostic/experimental pathology of breast cancer and alterations of plasma membrane components of lymphoma cells.


Grant
Agency: European Commission | Branch: FP7 | Program: CP | Phase: INFRA-2007-2.1-01 | Award Amount: 6.78M | Year: 2008

This is the project definition for the Conceptual Design Study of the large aperture European Solar Telescope (EST). EST is a pan-European project involving 29 partners from 14 different countries. A consortium EAST (European Association for Solar Telescopes) exists with the aim, among others, of undertaking the development of EST, to keep Europe in the frontier of Solar Physics in the world. EST will be optimised for studies of magnetic coupling between the deep photosphere and upper chromosphere. This will require diagnostics of the thermal, dynamic and magnetic properties of the plasma over many scale heights, by using multiple wavelength imaging, spectroscopy and spectropolarimetry. The EST design will strongly emphasise the use of a large number of visible and near-infrared instruments simultaneously, thereby improving photon efficiency and diagnostic capabilities relative to other existing or proposed ground-based or space-borne solar telescopes. To achieve these goals, EST must specialise in high spatial and temporal resolution using instruments that can efficiently produce two-dimensional spectral information. The study aims at demonstrating the scientific, technical and financial feasibility of EST. It includes key aspects needed for a conceptual design of the whole telescope, such as optomechanical design, cooling mechanisms, adaptive optics, instrumentation and control. Different existing alternatives will be analysed for all systems and subsystems, with decisions taken on the most adequate ones that are compatible with the scientific goals and the technical strategies. Technical specifications will be given at the end of the Design Study for all systems and subsystems.


Grant
Agency: European Commission | Branch: H2020 | Program: MSCA-ITN-ETN | Phase: MSCA-ITN-2014-ETN | Award Amount: 3.87M | Year: 2015

Cell migration (cell motility) is a fundamental biological process that is pivotal in (i) tissue formation and repair (health) and (ii) tissue invasion during carcinogenesis (disease). Understanding and controlling cell migration will have major clinical impact. Clarifying mechanisms driving cell motility has been challenging due to the complex underlying cellular mechanisms; these involve multiple components coordinated by structural, chemical and physical signals in terms of time and space. To accomplish breakthroughs in this field, researchers are needed who (i) master cutting-edge experimental techniques for monitoring the different cellular processes at high resolution and (ii) have competencies in theoretical science for integrating the resulting data sets into mechanistic mathematical models for predicting motile cell behaviour. The Research Training Network on Integrated Component Cycling in Epithelial Cell Motility (InCeM) aims to endow up-and-coming researchers with exactly these competencies. They will be able to develop and apply innovative devices for microscopic recording, image processing techniques, data analysis tools and modelling procedures for mechanistic understanding of cell migration. InCeM will focus on epithelial cells, since inducing motility in this cell type is clinically relevant for wound healing and cancer invasion. The ultimate goal is to control and manipulate cell migration for clinical applications. A dedicated multidisciplinary team of 11 beneficiaries from universities (4), research institutions (4) and industry (3), based in 5 European countries and Israel, together with 17 associated partners from the public and private sector, will train 15 Early Stage Researchers (ESRs) to use the relevant technologies and sciences and will offer business training to prepare them for successful careers in both academic and non-academic environments.


Grant
Agency: European Commission | Branch: H2020 | Program: RIA | Phase: INFRADEV-1-2014 | Award Amount: 3.96M | Year: 2015

The present project is intended to take the European Solar Telescope (EST) to the next level of development by undertaking crucial activities to improve the performance of current state-of-the-art instrumentation. Legal, industrial and socio-economic issues will also be addressed, as key questions for the attainment of EST. The particular developments and strategic tasks proposed here can be summarised in the following specific objectives: (i) Boosting new generation detectors, with the development of two prototype sensors, one for large-format imaging and a the other for high-precision polarimetry, the evaluation of an existing large format wavefront sensing camera is also addressed; (ii) Development of a capacitance-stabilised Fabry-Perot prototype for a high quality control of the parallelism of the etalon plates; (iii) new techniques for 2D solar spectro-polarimetry; with integral field units based on multi-slit image slicers or a microlens-fed spectrograph; (iv) development of large format liquid-crystal modulators, required for the large-format sensors that will be needed for the new generation large aperture telescopes ; (v) evaluation of the performance of the EST-MCAO deformable mirrors to improve the design and performance of this system; and (vi) strategic work to covering industrial, financial and legal issues related the future construction and operation of EST. The following issues will be addressed: Elaboration of a census of the European solar physics community Analysis of the technological expertise of European companies in the different countries and their potential expertise related with the construction needs of EST Revision and update of the construction budget of EST Stimulation of a discussion of all these aspects within the consortium EAST With all these elements in hand, the project will be in the condition to present a definite proposal for detailed design, construction, managing and operation of EST.


Patent
Andor Technology | Date: 2011-03-09

A digital interface interconnected between a controller for a spatial light modulator device and a pattern generation subsystem. The digital interface comprises a clock which provides a clock signal and a logic device responsive to pattern image data output by the pattern generation subsystem and the clock signal and configured to assign pixels to the pattern Image data and to serialize the assigned pixels according to the clock signal to reformat the pattern image data to correspond to the spatial addressing of the spatial light modulator device.

Loading Andor Technology collaborators
Loading Andor Technology collaborators